Evidence map›Paper›PMID 39407503›Full record

ArticleMolecules (Basel, Switzerland)2024

Rapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [

Yingqing Lu, Philip H Chao, Jeffrey Collins, R Michael van Dam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yingqing LuCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0002-0343-5179
Philip H ChaoCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0001-5633-0269
Jeffrey CollinsCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0003-2210-4655
R Michael van DamCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0003-2316-0173

Funding

Research Training in Biomedical PhysicsT32EB002101 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Michael F McNitt-Gray · 2003 to 2026
$5.3M
Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistryR41EB034168 · NIBIB · DROPLETPHARM INC. · PI JONES, JASON · 2023 to 2023
$276k
Radio-UPLC-MS for high-throughput analysis of short-lived radiolabeled compoundsS10OD026942 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2019 to 2019
$199k
NIBIB NIH HHS R41 EB034168NIBIB NIH HHS T32 EB002101NIH HHS S10 OD026942ODCDC CDC HHS S10 OD026942
6 · The paper itself

Abstract

The radiometal gallium-68 (Ga-68) has garnered significant interest due to its convenient production via compact and widely available generators and the high performance of

Indexed as

Gallium RadioisotopesEdetic AcidGallium IsotopesHumansIsotope LabelingPositron-Emission TomographyRadiopharmaceuticalsEdetic AcidGallium-68gallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesPSMA-11Radiopharmaceuticals[68Ga]Ga-PSMA-11droplet reactorGallium-68 (Ga-68)microscale radiosynthesisradiometalradionuclide concentration

Identifiers

PMID39407503
PMCPMC11477945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.